share_log

5 Value Stocks To Watch In The Healthcare Sector

5 Value Stocks To Watch In The Healthcare Sector

5 在醫療保健行業值得關注的價值股票
Benzinga Real-time News ·  2022/12/12 09:44

What are Value Stocks?

什麼是價值股?

A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.

與同行業公司的股票價格相比,價值股票的價格通常較低。這表明該公司的價值可能被低估,因為投資者並沒有對此類公司表達盡可能多的興趣。檢查價值的最常用方法是使用價格對盈利倍數或市盈率(P/E 倍數)。低 P/E 倍數表明股票價值被低估。

Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:

本辛加洞察已經編制了醫療保健行業的價值股清單,這些股票可能值得關注:

  1. Vicarious Surgical (NYSE:RBOT) - P/E: 6.22
  2. Walgreens Boots Alliance (NASDAQ:WBA) - P/E: 8.07
  3. Pfizer (NYSE:PFE) - P/E: 9.91
  4. Aadi Bioscience (NASDAQ:AADI) - P/E: 2.79
  5. Innoviva (NASDAQ:INVA) - P/E: 4.04
  1. 替代外科 (紐約證交所:方塊機器人)-P/E:6.22
  2. 沃爾格林靴子聯盟 (納斯達克:瓦巴)-P/E:8.07
  3. 輝瑞公司 (紐約證交所:全氟乙烯)-P/E: 9.91
  4. 阿迪生物科學 (納斯達克:阿迪)-P/E: 2.79
  5. 伊諾維娃 (納斯達克:因瓦)-P/E:4.04

Vicarious Surgical's earnings per share for Q3 sits at $-0.18, whereas in Q2, they were at -0.16. Most recently, Walgreens Boots Alliance reported earnings per share at $0.8, whereas in Q3 earnings per share sat at $0.96. Its most recent dividend yield is at 5.41%, which has increased by 0.35% from 5.06% in the previous quarter.

第三季度替代外科手術的每股收益為 -0.18 美元,而在第二季度則為 -0.16。最近,沃爾格林靴子聯盟報告了每股收益為 0.8 美元,而第三季度的每股收益為 0.96 美元。其最近期股息收益率為 5.41%,較上一季度的 5.06% 上升 0.35%。

Pfizer has reported Q3 earnings per share at $1.78, which has decreased by 12.75% compared to Q2, which was 2.04. Most recently, the company reported a dividend yield of 3.17%, which has decreased by 0.47% from last quarter's yield of 3.64%.

輝瑞公司報告第三季度的每股盈利為 1.78 美元,與第二季度相比下降了 12.75%,即 2.04 年第二季度。最近,該公司報告的股息收益率為 3.17%,較上一季度的 3.64% 的收益率下降了 0.47%。

Aadi Bioscience saw an increase in earnings per share from -0.69 in Q2 to $-0.68 now. Most recently, Innoviva reported earnings per share at $2.8, whereas in Q2 earnings per share sat at $0.05.

阿迪生物科學的每股收益從第二季度的 -0.69 增加到 -0.68 美元。最近,伊諾維娃報告了每股盈利為 2.8 美元,而第二季度每股盈利為 0.05 美元。

These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

這 5 種價值股票是由 營運洞察 基於量化分析。儘管這種有條不紊的判斷過程並不意味著做出最終決定,但我們的技術可以為投資者提供額外的認知。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論